John Hadden - Director, Plx Pharma Inc
As of December 15, 2020
John Hadden Net Worth
- Net worth is estimated to be at least $45.74K
- Owns at least 3,690 units of Plx Pharma Inc stock
John Hadden Trading
- Largest purchase of shares was 1,000 units , worth over $5.45K on December 15, 2020
- In total has made about 6 transactions over 3 years
- Usually trades in November and March, with the busiest year in 2020
JOHN HADDEN
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
John Hadden Mailing Address
- Mailing address is 1375 S Fort Harrison Ave Clearwater FL 33756 FL
Plx Pharma Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|---|
| Michael J. Valentino | 2019 | $234,375 | - | - | $327,200 | - | - | - | $680,325 |
| Michael J. Valentino | 2018 | $200,000 | - | - | - | - | - | - | $300,000 |
| Natasha Giordano | 2019 | $468,750 | - | - | $865,751 | - | - | $16,000 | $1,615,501 |
| Natasha Giordano | 2018 | $400,000 | - | - | - | - | - | $16,000 | $616,000 |
| Rita M. O’Connor | 2019 | $347,917 | - | - | $505,831 | - | - | $12,500 | $1,058,748 |
| Rita M. O’Connor | 2018 | $300,000 | - | - | - | - | - | $12,500 | $462,500 |
| Efthymios Deliargyris | 2019 | $353,750 | - | - | $245,400 | - | - | $12,500 | $801,650 |
| Efthymios Deliargyris | 2018 | $115,532 | - | - | $157,850 | - | - | $102,167 | $432,912 |
| No matching records found | |||||||||
Source: https://www.sec.gov/Archives/edgar/data/1497504/000092189520002477/def14a11577002_09252020.htm
Plx Pharma Inc Insider Trading
- The most recent transaction was 8,000 units bought on June 15, 2021 by Michael Valentino worth over $99.87K
- In the last 4 years, insiders at Plx Pharma Inc bought an estimated value of $2.48M
- The most active traders are Michael Valentino, Executive Chairman, John Hadden, Director, and Natasha Giordano, Chief Executive Officer
- Insider trading is most common in March, with the busiest year in 2020
PLx Pharma Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||